Ethnic patterns of cytologic abnormalities in cervical smears in suriname, a high-risk area for cervical cancer

Acta Cytologica

Volumn 50, Issue 6, 2006, Pages 621-626

  Vermeulen, Christine F W ^a,d   Grünberg, Antoon ^b   Peters, Lex A W ^a   Van Der Linden Narain, Ingrid B S ^a   Vrede, M Albert ^c   Krul, Eveline J T ^a   Dekker, Friedo W ^a   Fleuren, Gert Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Lobi Foundation   (Suriname)

^c ACADEMIC HOSPITAL PARAMARIBO   (Suriname)

^d Department of Pathology ^*  (Netherlands)

Author keywords

Cervical cancer; Cervical smears; Mass screening; Suriname

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER SCREENING; CARCINOMA IN SITU; CONTROLLED STUDY; ETHNOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SURINAME; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 33751177955     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000326030     Document Type: Article

References (27)

1. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Borras J, Parkin DM: Internationa] trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 2000;863:429-435
2. Parkin DM, Bray F, Ferlay J, Pisani P: Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;942:153-156
3. Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. Lyon, IARC Press, 2004
4. Gustafsson L, Ponten J, Bergstrom R, Adami HO: International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 1997;712:159-165
5. Sankaranarayanan R, Budukh AM, Rajkumar R: Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ 2001;7910:954-962
6. Pecorelli S, Benedet JL, Creasman WT, Shepherd JH: FIGO staging of gynecologic cancer. Int J Gynecol Obstet 1999;653:243-249
7. Hakama M, Chamberlain J, Day NE, Miller AB, Prorok PC: Evaluation of screening programs for gynecological cancer. Br J Cancer 1985;524:669-673
8. Control of cancer of the cervix uteri. Bull World Health Organ 1986;644:607-618
9. Nieminen P, Kallio M, Anttila A, Hakama M: Organised vs. spontaneous pap-smear screening for cervical cancer: A case-control study. Int J Cancer 1999;831:55-58
10. Krul EJT, Peters LAW, Vandenbroucke JP, Vrede MA, van Kanten RW, Fleuren GJ. Cervical carcinoma in Surinam: Incidence and staging of cervical carcinoma between 1989 and 1994. Cancer 1996;777:1329-1333
11. Krul EJT, Vijver van de MJ, Schuuring E, Kanten van RW, Peters AAW, Fleuren GJ: Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country. Int J Gynecol Cancer 1999;93:206-211
12. Giard RWM, Hermans J, Doornrwaard H: National results of cervix cytology diagnosis in 1992: Efficacy of screening could be improved. Ned Tijdschr Geneeskd 1994;13826:1325-1330
13. Doornewaard H, van der Schouw YT, van der Graaf Y, Bos AB, Habbema JDF, van den Tweel JG: The diagnostic value of computer-assisted primary cervical smear screening: A longitudinal cohort study. Mod Pathol 1999;1211:995-1000
14. Cheung ANY, Szeto EF, Ng KM, Fong KW, Yeung ACE, Tsun OKL, Khoo US, Chan KYK, Ng AWY: Atypical squamous cells of undetermined significance on cervical smears: Follow-up study of an Asian screening population. Cancer Cytopathol 2004;1022:74-80
15. Pitman MB, Cibas ES, Powers CN, Renshaw AA, Frable WJ: Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear. Cancer Cytopathol 2002;963:128-134
16. Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M: Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis. J Natl Cancer Inst 2003;951:46-52
17. Solomon D, Schiffman M, Tarone R: Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;934:293-299
18. Miller AB, Nazeer S, Fonn S, Brandup-Lukanow A, Rehman R, Cronje H, Sankaranarayanan R, Koroltchouk V, Syrjänen K, Singer A, Onsrud M on behalf of the participants: Report on Consensus Conference on Cervical Cancer Screening and Management. Int J Cancer 2000;863:440-447
19. Anttila A, Pukkala E, Soderman B, Kallio M, Nieminen P, Hakama M: Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: Recent increase in cervical cancer incidence. Int J Cancer 1999;831:59-65
20. Nieminen P, Hakama M, Viikki M, Tarkkanen J, Anttila A. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: Results of the first year. Int J Cancer 2003;1033:422-426
21. Ballegooijen MV, Rebolj M, Meerding WJ, Akker-van Marle MEVD, Berkers LM, Habbema JDF: Practice of Population Screening for Cervical Cancer in 2001. Rotterdam, Department of Public Health, Erasmus Medical Center, 2003
22. Robyr R, Nazeer S, Vassikkos P, Matute JC, Sando Z, Halle G, Mbakop A, Campana A: Feasibility of cytology-based cervical cancer screening in rural Cameroon. Acta Cytol 2002;466:1110-1116
23. http://www.sbbw.nl/extra/faarverslag/Jaarverslag2002.pdf, Accessed June 2005
24. Bulkmans NWJ, Rozendaal L, Snijders PJF, Voorhorst FJ, Boeke AJP, Zandwijken GRJ, van Kemenade FJ, Verheijen RHM, von Groningen K, Boon ME, Keuning HJF, van Ballegooijen M, Van den Brule AJC, Meijer CJLM: Pobascam, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: Design, methods and baseline data of 44,102 women. Int J Cancer 2004;1101:94-101
25. Syrjanen K, Yliskoski M, Kataja V, Hippelainen M, Syrjanen S, Saarikoski S, Ryhanen A: Prevalence of genital human papillomavirus infections in a mass-screened Finnish female population aged 20-65 years. Int J STD AIDS 1990;16:410-415
26. Syrjanen K, Hakama M, Saarikoski S, Vayrynen M, Yliskoski M, Syrjanen S, Kataja V, Castren O: Prevalence, incidence, and estimated lifetime risk of cervical human papillomavirus Infections in a nonselected Finnish female-population. Sex Transm Dis 1990;171:15-19
27. Solomon D, Nayar R: The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. New York, Springer, 2003, p 191